bbio market cap june 2023

On June 30, 2023, BridgeBio Pharma (BBIO) had a market capitalization of $2.8B, based on 160.54M shares at a price of $17.20.

DATE CLOSE VOLUME OUTSTANDING MARKET CAP
June 30 2023
$17.20
1,550,400
160,535,400
$2,761,208,880.00
June 29 2023
$16.99
3,520,800
160,535,400
$2,727,496,446.00
June 28 2023
$18.01
2,658,600
160,535,400
$2,891,242,554.00
June 27 2023
$16.29
1,179,600
160,535,400
$2,615,121,666.00
June 26 2023
$15.49
1,284,100
160,535,400
$2,486,693,346.00
June 23 2023
$15.66
2,377,600
160,535,400
$2,513,984,364.00
June 22 2023
$16.14
1,959,300
160,535,400
$2,591,041,356.00
June 21 2023
$16.75
1,814,200
160,535,400
$2,688,967,950.00
June 20 2023
$16.52
3,179,900
160,535,400
$2,652,044,808.00
June 16 2023
$15.01
7,912,900
160,535,400
$2,409,636,354.00
June 15 2023
$15.52
2,021,900
160,535,400
$2,491,509,408.00
June 14 2023
$16.89
1,527,900
160,535,400
$2,711,442,906.00
June 13 2023
$16.75
1,730,900
160,535,400
$2,688,967,950.00
June 12 2023
$15.81
1,345,500
160,535,400
$2,538,064,674.00
June 09 2023
$16.00
1,207,600
160,535,400
$2,568,566,400.00
June 08 2023
$16.29
2,035,800
160,535,400
$2,615,121,666.00
June 07 2023
$16.56
1,348,800
160,535,400
$2,658,466,224.00
June 06 2023
$16.04
2,833,200
160,535,400
$2,574,987,816.00
June 05 2023
$14.60
823,600
160,535,400
$2,343,816,840.00
June 02 2023
$14.26
924,600
160,535,400
$2,289,234,804.00
June 01 2023
$14.00
935,100
160,535,400
$2,247,495,600.00